| __timestamp | Sanofi | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 21769000000 | 1256834000000 |
| Thursday, January 1, 2015 | 23942000000 | 1271973000000 |
| Friday, January 1, 2016 | 23995000000 | 1173296000000 |
| Sunday, January 1, 2017 | 24774000000 | 1274610000000 |
| Monday, January 1, 2018 | 24356000000 | 1437534000000 |
| Tuesday, January 1, 2019 | 25655000000 | 2201424000000 |
| Wednesday, January 1, 2020 | 25212000000 | 2203504000000 |
| Friday, January 1, 2021 | 26920000000 | 2462160000000 |
| Saturday, January 1, 2022 | 31697000000 | 2783406000000 |
| Sunday, January 1, 2023 | 31797000000 | 2832257000000 |
| Monday, January 1, 2024 | 2832257000000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding the financial health of leading companies is crucial. This analysis delves into the gross profit performance of two giants: Sanofi and Takeda Pharmaceutical Company Limited, from 2014 to 2023. Over this decade, Takeda consistently outperformed Sanofi, with its gross profit peaking at approximately 2.8 trillion in 2023, marking a 125% increase from 2014. In contrast, Sanofi's gross profit saw a more modest growth, reaching around 31.8 billion in 2023, a 46% rise from its 2014 figures. Notably, 2022 and 2023 were standout years for both companies, with Sanofi achieving its highest growth rate, while Takeda maintained its upward trajectory. However, data for Sanofi in 2024 is missing, leaving room for speculation on its future performance. This financial snapshot offers valuable insights into the competitive landscape of the pharmaceutical sector.
Gross Profit Analysis: Comparing Merck & Co., Inc. and Sanofi
Gross Profit Comparison: Pfizer Inc. and Sanofi Trends
Sanofi vs Alnylam Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Research and Development: Comparing Key Metrics for Sanofi and Takeda Pharmaceutical Company Limited
Who Optimizes SG&A Costs Better? Sanofi or Takeda Pharmaceutical Company Limited
Gross Profit Trends Compared: Sanofi vs Dr. Reddy's Laboratories Limited
Gross Profit Trends Compared: Sanofi vs Amneal Pharmaceuticals, Inc.
Key Insights on Gross Profit: Sanofi vs Veracyte, Inc.
Gross Profit Comparison: Vertex Pharmaceuticals Incorporated and Takeda Pharmaceutical Company Limited Trends
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs Genmab A/S
Takeda Pharmaceutical Company Limited vs Dr. Reddy's Laboratories Limited: A Gross Profit Performance Breakdown
Takeda Pharmaceutical Company Limited vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown